{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:20:26Z","timestamp":1780586426605,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013780","name":"LGMD2I Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ymthe.2024.06.028","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T18:33:13Z","timestamp":1719081193000},"page":"2604-2623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dual FKRP\/FST gene therapy normalizes ambulation, increases strength, decreases pathology, and amplifies gene expression in LGMDR9 mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Patricia","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ashbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macey","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-6191","authenticated-orcid":false,"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.06.028_bib1","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1093\/hmg\/ddv475","article-title":"Adeno-associated viral vectors for the treatment of hemophilia","volume":"25","author":"High","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.06.028_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3389\/fimmu.2020.00618","article-title":"Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A","volume":"11","author":"Samelson-Jones","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1055\/a-1384-0818","article-title":"Gene Therapy for Inherited Retinal Disorders: Update on Clinical Trials","volume":"238","author":"Michalakis","year":"2021","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"10.1016\/j.ymthe.2024.06.028_bib4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ophtha.2012.11.048","article-title":"Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2","volume":"120","author":"Testa","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2024.06.028_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.06.028_bib7","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/hmg\/10.25.2851","article-title":"Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C","volume":"10","author":"Brockington","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.06.028_bib8","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","article-title":"Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies","volume":"19","author":"Chan","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.06.028_bib9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/324412","article-title":"Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan","volume":"69","author":"Brockington","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2024.06.028_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9440(10)63160-4","article-title":"Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies","volume":"164","author":"Brown","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.06.028_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1096\/fj.07-8354com","article-title":"SEA domain proteolysis determines the functional composition of dystroglycan","volume":"22","author":"Akhavan","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2024.06.028_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib14","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1074\/jbc.R200031200","article-title":"Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function","volume":"278","author":"Michele","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.06.028_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature00837","article-title":"Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies","volume":"418","author":"Michele","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.06.028_bib16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/glycob\/cwv021","article-title":"Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane","volume":"25","author":"Yoshida-Moriguchi","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2024.06.028_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1214115","article-title":"Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE","volume":"335","author":"Inamori","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.06.028_bib18","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/glycob\/cwq082","article-title":"Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle","volume":"20","author":"Nilsson","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2024.06.028_bib19","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1114836108","article-title":"Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317\/319 is required for laminin binding and arenavirus infection","volume":"108","author":"Hara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.06.028_bib20","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","article-title":"Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy","volume":"14","author":"Kanagawa","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.06.028_bib21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2013.156","article-title":"Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of alpha-dystroglycan and improves muscle functions","volume":"21","author":"Xu","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib22","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/mt.2014.141","article-title":"Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery","volume":"22","author":"Qiao","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib23","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.ajpath.2015.03.017","article-title":"Restoration of Functional Glycosylation of alpha-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration","volume":"185","author":"Awano","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib24","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/hmg\/ddx066","article-title":"AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression","volume":"26","author":"Gicquel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.06.028_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JND-170255","article-title":"Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy","volume":"4","author":"Kanagawa","year":"2017","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2024.06.028_bib26","doi-asserted-by":"crossref","first-page":"e0278482","DOI":"10.1371\/journal.pone.0278482","article-title":"Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model","volume":"17","author":"Wu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.06.028_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-019-0206-1","article-title":"NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy","volume":"9","author":"Bailey","year":"2019","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2024.06.028_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.omtm.2019.12.005","article-title":"ISPD Overexpression Enhances Ribitol-Induced Glycosylation of alpha-Dystroglycan in Dystrophic FKRP Mutant Mice","volume":"17","author":"Cataldi","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.06.028_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtm.2017.02.002","article-title":"Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene","volume":"5","author":"Vannoy","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.06.028_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2018.10.004","article-title":"Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice","volume":"11","author":"Vannoy","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.06.028_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2004.01.046","article-title":"Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis","volume":"270","author":"Amthor","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib32","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double muscling in cattle due to mutations in the myostatin gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.06.028_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.06.028_bib34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.06.028_bib36","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.06.028_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2007.01.011","article-title":"Myostatin does not regulate cardiac hypertrophy or fibrosis","volume":"17","author":"Cohn","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2024.06.028_bib38","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.0604893104","article-title":"Lack of myostatin results in excessive muscle growth but impaired force generation","volume":"104","author":"Amthor","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.06.028_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/mt.2009.322","article-title":"Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice","volume":"18","author":"Dumonceaux","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mus.27259","article-title":"A phase Ib\/IIa, open-label, multiple ascending-dose trial of domagrozumab in fukutin-related protein limb-girdle muscular dystrophy","volume":"64","author":"Leung","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2024.06.028_bib41","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.06.028_bib42","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1371\/journal.pone.0000789","article-title":"Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways","volume":"2","author":"Lee","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.06.028_bib43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.201109091","article-title":"Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin","volume":"197","author":"Winbanks","year":"2012","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib44","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in\u00a0vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2017.02.015","article-title":"Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes","volume":"25","author":"Mendell","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21244","article-title":"Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease","volume":"39","author":"Rodino-Klapac","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2024.06.028_bib48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/gt.2008.49","article-title":"Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES","volume":"15","author":"Delluc-Clavieres","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0092-8674(02)00907-8","article-title":"Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration","volume":"110","author":"Cohn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.06.028_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2044-5040-1-31","article-title":"Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity","volume":"1","author":"Krag","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2024.06.028_bib51","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1152\/japplphysiol.00287.2017","article-title":"Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i","volume":"123","author":"Maricelli","year":"2017","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib52","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.32607\/actanaturae.11063","article-title":"Muscle-Specific Promoters for Gene Therapy","volume":"13","author":"Skopenkova","year":"2021","journal-title":"Acta Naturae"},{"key":"10.1016\/j.ymthe.2024.06.028_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2022.08.009","article-title":"A first-in-human phase I\/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2","volume":"27","author":"Flanigan","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.06.028_bib55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib56","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1093\/hmg\/ddt342","article-title":"Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model","volume":"22","author":"Rodino-Klapac","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.06.028_bib57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ymthe.2005.04.001","article-title":"Phenotypic improvement of dystrophic muscles by rAAV\/microdystrophin vectors is augmented by Igf1 codelivery","volume":"12","author":"Abmayr","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00256-004-0825-3","article-title":"Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging","volume":"34","author":"Marden","year":"2005","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib59","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1148\/radiology.186.2.8421754","article-title":"Duchenne muscular dystrophy: MR grading system with functional correlation","volume":"186","author":"Liu","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.ymthe.2024.06.028_bib60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1259\/0007-1285-63-756-946","article-title":"Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement","volume":"63","author":"Lamminen","year":"1990","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib61","first-page":"91","article-title":"Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle","volume":"30","author":"Broccolini","year":"2011","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omtm.2023.05.022","article-title":"Efficacy and muscle safety assessment of fukutin-related protein gene therapy","volume":"30","author":"Benasutti","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.06.028_bib63","doi-asserted-by":"crossref","first-page":"16385","DOI":"10.1038\/s41598-020-73315-6","article-title":"Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy","volume":"10","author":"Sugihara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.06.028_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.06.028_bib65","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2008-01-131375","article-title":"Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy","volume":"113","author":"Velazquez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.06.028_bib66","doi-asserted-by":"crossref","first-page":"e70993","DOI":"10.1371\/journal.pone.0070993","article-title":"Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study","volume":"8","author":"Willis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.06.028_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtm.2018.06.002","article-title":"An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.GALGT2 to Leg Skeletal Muscles in the Rhesus Macaque","volume":"10","author":"Xu","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.06.028_bib68","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib69","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.06.028_bib70","doi-asserted-by":"crossref","first-page":"e12785","DOI":"10.1111\/nan.12785","article-title":"Automated immunofluorescence analysis for sensitive and precise dystrophin quantification in muscle biopsies","volume":"48","author":"Vetter","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymthe.2024.06.028_bib71","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624004118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624004118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T02:52:56Z","timestamp":1763779976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624004118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1525001624004118"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.06.028","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual FKRP\/FST gene therapy normalizes ambulation, increases strength, decreases pathology, and amplifies gene expression in LGMDR9 mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}